Our findings demonstrate retinal and brain Cp inclusions in 60–79% of early AD (MCI) patients and 100% of AD dementia patients as compared with 38–40% of age- and sex-matched NC individuals, while not reaching significance for prodromal AD (MCI). This evidence concerns the gene CP and Alzheimer disease.